influenza
virus
iav
caus
season
pandem
epidem
high
morbid
mortal
call
effect
antiiav
agent
glycoprotein
hemagglutinin
influenza
viru
play
crucial
role
initi
stage
viru
infect
make
potenti
target
antiinfluenza
therapeut
develop
found
quercetin
inhibit
influenza
infect
wide
spectrum
strain
includ
apuerto
half
maxim
inhibitori
concentr
ic
respect
mechan
studi
identifi
quercetin
show
interact
subunit
moreov
quercetin
could
inhibit
entri
viru
use
pseudovirusbas
drug
screen
system
studi
indic
quercetin
show
inhibitori
activ
earli
stage
influenza
infect
provid
futur
therapeut
option
develop
effect
safe
afford
natur
product
treatment
prophylaxi
iav
infect
influenza
virus
iav
caus
worldwid
outbreak
season
pandem
serious
impact
public
health
well
economi
subtyp
swine
influenza
lineag
continu
circul
human
seriou
concern
rais
pandem
potenti
addit
highli
pathogen
avian
influenza
viru
caus
acut
respiratori
distress
syndrom
multiorgan
failur
approxim
lethal
reassort
influenza
viru
led
extra
pulmonari
complic
fatal
rate
sinc
first
case
diseas
found
china
genet
variat
influenza
virus
result
genet
drift
genet
shift
caus
select
pressur
environ
host
immun
respons
make
almost
imposs
produc
time
suffici
effect
vaccin
prevent
epidem
outbreak
consequ
develop
novel
strategi
urgent
need
prevent
spread
influenza
viru
among
antiinfluenza
agent
consid
effect
intervent
tool
control
viru
infect
antiinfluenza
viral
activ
quercetin
influenza
viru
evalu
measur
inhibit
cell
infect
model
mdck
cell
infect
influenza
viru
presenc
quercetin
cytopath
effect
cpe
observ
h
postinfect
parallel
inhibit
rate
repres
determin
cell
viabil
cpe
inhibit
figur
use
mtt
assay
data
indic
quercetin
exert
obviou
inhibitori
effect
viru
strain
infect
dosedepend
manner
ic
ic
valu
list
tabl
consid
inhibit
rate
observ
inhibit
influenza
viru
apuerto
rel
lower
strain
subsequ
explor
mechan
antiinfluenza
activ
influenza
apuerto
viru
strain
investig
inhibitori
effect
quercetin
influenza
viru
infect
conduct
quantit
realtim
pcr
determin
quercetin
inhibit
synthesi
viral
mrna
mdck
cell
cell
cell
infect
influenza
apuerto
viru
tcid
presenc
quercetin
describ
experiment
section
total
rna
isol
infect
cell
analys
quantit
realtim
pcr
use
primer
specif
viral
ha
mrna
h
postinfect
result
reveal
quercetin
reduc
ha
mrna
transcript
influenzavirusinfect
cell
dosedepend
manner
figur
investig
inhibitori
effect
quercetin
influenza
viru
infect
conduct
quantit
realtim
pcr
determin
quercetin
inhibit
synthesi
viral
mrna
mdck
cell
cell
cell
infect
influenza
apuerto
viru
presenc
quercetin
describ
experiment
section
total
rna
isol
infect
cell
analys
quantit
realtim
pcr
use
primer
specif
viral
ha
mrna
h
postinfect
result
reveal
quercetin
reduc
ha
mrna
transcript
influenzavirusinfect
cell
dosedepend
manner
figur
confirm
quercetin
also
impair
viral
protein
express
mdck
cell
infect
influenza
apuerto
viru
presenc
variou
concentr
quercetin
h
postinfect
cell
analyz
viru
nucleoprotein
np
local
indirect
immunofluoresc
assay
data
shown
figur
quercetin
show
signific
inhibit
viral
np
protein
synthesi
dosedepend
way
mdck
cell
data
adequ
illustr
quercetin
could
effect
inhibit
influenza
viru
infect
inspir
us
detect
mechan
quercetin
inhibit
influenza
viru
infect
identifi
antiinfluenza
activ
quercetin
hope
explor
potenti
mechan
antiinfluenza
activ
yu
et
al
report
one
life
cycl
influenza
viru
around
h
divid
three
step
viru
entri
h
viral
genom
replic
translat
h
progeni
virion
releas
h
identifi
step
quercetin
target
influenza
viru
infect
perform
timeofaddit
assay
studi
inhibitori
effect
quercetin
infect
cell
treat
quercetin
h
h
h
h
h
time
interv
viru
infect
respect
ha
protein
mrna
express
level
detect
western
blot
quantit
realtim
pcr
repres
extent
viru
infect
figur
b
show
quercetin
inhibit
viral
ha
express
mainli
h
entri
step
h
whole
life
cycl
time
interv
inhibitori
effect
time
interv
clear
data
demonstr
quercetin
may
inhibit
viru
infect
earli
stage
cover
viral
attach
endocytosi
viralcel
fusion
addit
conduct
anoth
relev
test
determin
effect
quercetin
viru
entri
figur
serial
dilut
compound
ad
cell
time
viru
absorpt
h
pi
post
infect
h
postinfect
h
pi
former
infect
inoculum
contain
test
compound
replac
fresh
medium
contain
tpcktrypsin
h
incub
latter
compound
ad
viru
infect
h
postinfect
inhibit
rate
influenza
infect
detect
mtt
assay
result
demonstr
quercetin
inhibit
viru
infect
ad
process
viru
infect
rather
postviru
infect
confirm
quercetin
also
impair
viral
protein
express
mdck
cell
infect
influenza
apuerto
viru
tcid
presenc
variou
concentr
quercetin
h
postinfect
cell
analyz
viru
nucleoprotein
np
local
indirect
immunofluoresc
assay
data
shown
figur
quercetin
show
signific
inhibit
viral
np
protein
synthesi
dosedepend
way
mdck
cell
data
adequ
illustr
quercetin
could
effect
inhibit
influenza
viru
infect
inspir
us
detect
mechan
quercetin
inhibit
influenza
viru
infect
identifi
antiinfluenza
activ
quercetin
hope
explor
potenti
mechan
antiinfluenza
activ
yu
et
al
report
one
life
cycl
influenza
viru
around
h
divid
three
step
viru
entri
h
viral
genom
replic
translat
h
progeni
virion
releas
h
identifi
step
quercetin
target
influenza
viru
infect
perform
timeofaddit
assay
studi
inhibitori
effect
quercetin
infect
cell
treat
quercetin
h
h
h
h
h
time
interv
viru
infect
respect
ha
protein
mrna
express
level
detect
western
blot
quantit
realtim
pcr
repres
extent
viru
infect
figur
addit
determin
whether
quercetin
target
host
cell
virion
design
three
mode
treatment
assay
previous
report
modif
figur
show
first
mode
treatment
name
cotreat
mdck
cell
inocul
influenza
viru
presenc
quercetin
h
subsequ
wash
remov
unbound
virus
compound
second
mode
name
pretreat
cell
cell
incub
quercetin
min
subsequ
wash
remov
unbound
compound
pretreat
cell
expos
virus
h
subsequ
wash
remov
unbound
virus
third
experi
call
pretreat
viru
viru
incub
quercetin
min
unbound
compound
subsequ
remov
viru
ultrafiltr
host
cell
inocul
pretreat
virus
h
subsequ
wash
remov
unbound
virus
cell
treat
cultur
h
inhibitori
effect
measur
mtt
assay
accord
data
figur
cotreat
quercetin
concentr
exert
inhibit
rate
pretreat
viru
led
inhibit
rate
pretreat
cell
almost
detect
effect
conclud
quercetin
may
target
influenza
viru
particl
rather
host
cell
addit
determin
whether
quercetin
target
host
cell
virion
design
three
mode
treatment
assay
previous
report
modif
figur
show
first
mode
treatment
name
cotreat
mdck
cell
inocul
influenza
viru
presenc
quercetin
h
subsequ
wash
remov
unbound
virus
compound
second
mode
name
pretreat
cell
cell
incub
quercetin
min
subsequ
wash
remov
unbound
compound
pretreat
cell
expos
virus
h
subsequ
wash
remov
unbound
virus
third
experi
call
pretreat
viru
viru
incub
quercetin
min
unbound
compound
subsequ
remov
viru
ultrafiltr
host
cell
inocul
pretreat
virus
h
subsequ
wash
remov
unbound
virus
cell
treat
cultur
h
inhibitori
effect
measur
mtt
assay
accord
data
figur
cotreat
quercetin
concentr
exert
inhibit
rate
pretreat
viru
led
inhibit
rate
pretreat
cell
almost
detect
effect
conclud
quercetin
may
target
influenza
viru
particl
rather
host
cell
h
subsequ
wash
remov
unbound
virus
cell
treat
cultur
h
inhibitori
effect
measur
mtt
assay
accord
data
figur
cotreat
quercetin
concentr
exert
inhibit
rate
pretreat
viru
led
inhibit
rate
pretreat
cell
almost
detect
effect
conclud
quercetin
may
target
influenza
viru
particl
rather
host
cell
viral
envelop
protein
hemagglutinin
play
critic
role
viru
entri
matur
ha
compos
two
disulfidelink
subunit
respons
viru
bind
subunit
respons
viralcel
fusion
specul
bind
affin
ha
protein
quercetin
confirm
surfac
plasmon
reson
spr
assay
design
detect
bind
two
molecul
quercetin
show
mediumbind
affin
ha
protein
k
valu
cucurmin
shown
possess
antiinfluenza
viru
entri
activ
use
posit
control
k
valu
assay
figur
confirm
bind
affin
quercetin
ha
protein
conduct
microscal
thermophoresi
mst
assay
allow
quantit
analysi
interact
small
molecul
protein
infre
solut
low
sampl
consumpt
interact
small
molecul
protein
induc
molecular
chang
size
charg
hydrat
shell
conform
affect
molecul
mobil
process
thermophoresi
result
demonstr
quercetin
interact
influenza
ha
protein
dosedepend
manner
compound
report
previous
interact
influenza
ha
protein
use
posit
control
figur
bind
affin
ha
protein
kd
valu
cucurmin
shown
possess
antiinfluenza
viru
entri
activ
use
posit
control
kd
valu
assay
figur
confirm
bind
affin
quercetin
ha
protein
conduct
microscal
thermophoresi
mst
assay
allow
quantit
analysi
interact
small
molecul
protein
infre
solut
low
sampl
consumpt
interact
small
molecul
protein
induc
molecular
chang
size
charg
hydrat
shell
conform
affect
molecul
mobil
process
thermophoresi
result
demonstr
quercetin
interact
influenza
ha
protein
dosedepend
manner
compound
report
previous
interact
influenza
ha
protein
use
posit
control
figur
curcumin
ha
protein
spr
assay
compound
immobil
sensor
chip
recombin
influenza
ha
protein
inject
analyt
variou
concentr
dissolv
run
buffer
flow
rate
contact
time
dissoci
time
respect
chip
platform
regener
glyhcl
ph
wash
run
buffer
curcumin
use
posit
control
assay
affin
constant
kd
ratio
dissoci
constant
kd
associ
constant
ka
kd
kdka
order
detect
domain
quercetin
target
first
design
hemagglutinin
inhibit
hi
assay
detect
whether
quercetin
could
interfer
interact
ha
cellular
receptor
subsequ
prevent
viru
attach
cell
data
show
inhibitori
effect
viral
attach
cell
mainli
mediat
ha
subunit
wonder
quercetin
could
interfer
viralcel
membran
fusion
mediat
subunit
subsequ
hemolysi
assay
perform
influenza
viru
apuerto
determin
effect
quercetin
fusion
trigger
hemolysi
viruscel
suspens
briefli
acidifi
ph
initi
ha
conform
chang
lyse
chicken
red
blood
cell
crbc
well
absent
viru
use
control
determin
effect
compound
crbc
result
indic
quercetin
could
inhibit
influenzavirushamedi
hemolysi
dosedepend
manner
indic
quercetin
may
target
membran
fusion
process
viru
entri
figur
order
detect
domain
quercetin
target
first
design
hemagglutinin
inhibit
hi
assay
detect
whether
quercetin
could
interfer
interact
ha
cellular
receptor
subsequ
prevent
viru
attach
cell
data
show
inhibitori
effect
viral
attach
cell
mainli
mediat
ha
subunit
wonder
quercetin
could
interfer
viralcel
membran
fusion
mediat
subunit
subsequ
hemolysi
assay
perform
influenza
viru
apuerto
determin
effect
quercetin
fusion
trigger
hemolysi
viruscel
suspens
briefli
acidifi
ph
initi
ha
conform
chang
lyse
chicken
red
blood
cell
crbc
well
absent
viru
use
control
determin
effect
compound
crbc
result
indic
quercetin
could
inhibit
influenzavirushamedi
hemolysi
dosedepend
manner
indic
quercetin
may
target
membran
fusion
process
viru
entri
figur
trigger
hemolysi
viruscel
suspens
briefli
acidifi
ph
initi
ha
conform
chang
lyse
chicken
red
blood
cell
crbc
well
absent
viru
use
control
determin
effect
compound
crbc
result
indic
quercetin
could
inhibit
influenzavirushamedi
hemolysi
dosedepend
manner
indic
quercetin
may
target
membran
fusion
process
viru
entri
figur
use
virallik
particl
pseudotyp
hiv
backbon
plasmid
influenza
envelop
glycoproein
ha
plasmid
iav
viru
strain
includ
tabl
contrari
quercetin
effect
infect
vsvg
pseudoviru
figur
demonstr
quercetin
specif
interf
function
influenza
ha
envelop
protein
data
reconfirm
result
confirm
quercetin
could
effect
inhibit
influenza
viru
entri
interact
ha
protein
figur
valu
shown
tabl
quercetin
effect
infect
vsvg
pseudoviru
figur
demonstr
rcetin
specif
interf
function
influenza
ha
envelop
protein
reconfirm
result
confirm
quercetin
could
effect
inhibit
influenza
viru
rough
interact
ha
protein
vitro
cytotox
quercetin
test
mtt
assay
quercetin
exhibit
signific
cytotox
mdck
cell
cell
concentr
high
influenza
virus
continu
emerg
unpredict
annual
associ
signific
morbid
mortal
particularli
circul
high
pathogen
avian
influ
unfortun
side
effect
appear
drugresist
current
avail
iav
drug
limit
clinic
use
novel
antiinfluenza
viru
agent
especi
targeti
newli
develop
target
remain
clinic
develop
life
cycl
influenza
viru
includ
viral
attach
entri
replic
blockad
viral
entryfus
would
certainli
promis
therapeut
strategi
fight
ag
viru
infect
includ
middl
east
respiratori
symptom
coronaviru
merscov
influenza
viru
remark
applic
hiv
fusion
inhibitor
enfuvirtid
alon
combin
antiviru
agent
becom
attract
antivir
strategi
moreov
natur
small
molecul
potenti
entri
inhibitor
object
resear
mani
year
howev
date
drugblock
viral
entri
avail
trea
prevent
influenza
initi
studi
found
quercetin
display
antivir
activ
dif
influenza
viru
strain
includ
impel
us
investig
mecha
antiinfluenza
activ
surprisingli
found
inhibitori
effect
quercetin
enhanc
viru
preincub
quercetin
cell
infect
vi
presenc
quercetin
time
addit
assay
indic
quercetin
effec
inhibit
viru
infect
ad
viru
entri
stage
inhibitori
eff
vitro
cytotox
quercetin
test
mtt
assay
quercetin
exhibit
signific
cytotox
mdck
cell
cell
concentr
high
influenza
virus
continu
emerg
unpredict
annual
associ
signific
morbid
mortal
particularli
circul
high
pathogen
avian
influenza
unfortun
side
effect
appear
drugresist
current
avail
antiiav
drug
limit
clinic
use
novel
antiinfluenza
viru
agent
especi
target
newli
develop
target
remain
clinic
develop
life
cycl
influenza
viru
includ
viral
attach
entri
replic
releas
blockad
viral
entryfus
would
certainli
promis
therapeut
strategi
fight
viru
infect
includ
middl
east
respiratori
symptom
coronaviru
merscov
influenza
viru
remark
applic
hiv
fusion
inhibitor
enfuvirtid
either
alon
combin
antiviru
agent
becom
attract
antivir
strategi
moreov
natur
small
molecul
potenti
entri
inhibitor
object
research
mani
year
howev
date
drugblock
viral
entri
avail
treatment
prevent
influenza
initi
studi
found
quercetin
display
antivir
activ
differ
influenza
viru
strain
includ
impel
us
investig
mechan
antiinfluenza
activ
surprisingli
found
inhibitori
effect
quercetin
enhanc
viru
preincub
quercetin
cell
infect
viru
presenc
quercetin
time
addit
assay
indic
quercetin
effect
inhibit
viru
infect
ad
viru
entri
stage
inhibitori
effect
stage
less
clear
basi
result
wonder
whether
quercetin
target
virion
cell
three
differ
mode
treatment
name
cotreat
pretreat
cell
pretreat
viru
found
quercetin
target
influenza
viral
particl
instead
host
cell
gener
ha
essenti
major
glycoprotein
surfac
influenza
viru
respons
entri
fusion
virion
sever
studi
identifi
inhibitor
receptor
bind
membran
fusion
activ
ha
particularli
latter
specul
quercetin
could
interact
ha
subsequ
interfer
viru
entri
use
two
procedur
assess
whether
bind
affin
quercetin
ha
protein
first
bind
affin
measur
spr
assay
result
indic
quercetin
show
medium
bind
affin
influenza
ha
protein
spr
assay
perform
immobil
one
bind
partner
thin
nobl
metal
film
surfac
immobil
therein
may
affect
bound
molecul
dynam
thu
alter
bind
event
subsequ
solutionbas
mst
assay
perform
confirm
bind
affin
quercetin
ha
solutionbas
method
microscal
thermophoresi
avoid
surfac
artifact
immobil
procedur
instead
one
bind
partner
fluoresc
label
mst
assay
provid
strong
support
result
spr
confirm
quercetin
exhibit
bind
affin
ha
follow
design
util
multipl
assay
identifi
potenti
target
quercetin
hi
assay
hemolysi
inhibit
assay
indic
quercetin
effici
inhibit
entri
influenza
viru
may
mainli
ascrib
interact
subunit
mediat
low
phinduc
fusion
viral
envelop
endosom
membran
addit
influenza
pseudoviru
neutral
assay
show
quercetin
potent
neutral
differ
strain
ha
pseudotyp
virus
reconfirm
quercetin
may
target
viral
surfac
ha
protein
thu
inhibit
viru
infect
studi
indic
quercetin
may
exert
antivir
activ
via
interact
viral
ha
protein
inhibit
viru
entri
cell
know
entri
inhibitor
name
tbhq
restrain
viru
infect
concentr
prevent
conform
chang
ha
low
ph
whether
quercetin
could
bind
hydrophob
pocket
form
interfac
ha
monom
like
tbhq
mechan
inhibit
influenza
viru
entri
studi
unravel
structureact
relationship
underway
laboratori
hand
combin
applic
multipl
therapeut
method
provid
sever
advantag
singleag
treatment
enhanc
antivir
potenc
reduc
drug
dosag
delay
emerg
drug
resist
fewer
side
effect
sinc
antivir
mechan
quercetin
differ
commonli
prescrib
antiinfluenza
drug
may
prove
effect
use
combin
antiretrovir
agent
explor
potenti
synergist
antivir
effect
quercetin
antiretrovir
agent
vitro
vivo
furthermor
noteworthi
quercetin
also
avail
dietari
supplement
daili
dose
mg
manufactur
recommend
countri
may
present
potenti
anim
feed
addit
reduc
risk
avian
influenza
viru
infect
poultri
farm
accordingli
quercetin
new
addit
antiinfluenza
treatment
continu
effort
made
modif
quercetin
enhanc
pharmacokinet
pharmacodynam
studi
demonstr
quercetin
novel
antivir
agent
may
use
effect
safe
afford
chemoprophylaxi
treatment
influenza
infect
importantli
quercetin
target
subunit
influenza
hemagglutinin
provid
new
insight
develop
class
antiinfluenza
fusion
inhibitor
cell
madin
darbi
canin
kidney
mdck
cell
human
lung
epitheli
cell
obtain
american
type
cultur
collect
atcc
manassa
va
usa
cell
mdck
cell
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
fb
penicillinstreptomycin
cell
maintain
medium
contain
fb
penicillinstreptomycin
viru
stock
laboratoryadapt
strain
includ
apuerto
propag
allanto
caviti
embryon
hen
egg
two
day
afterward
allanto
fluid
harvest
centrifug
rpm
min
store
use
viru
titer
determin
analysi
tissu
cultur
infect
dose
tcid
evalu
use
method
develop
reed
muench
quercetin
purchas
must
biotech
chengdu
china
puriti
synthet
laboratori
puriti
curcumin
bought
sigmaaldrich
st
loui
mo
usa
antivir
activ
quercetin
evalu
cytopath
effect
reduct
assay
previous
report
modif
briefli
mdck
cell
seed
plate
cellswel
incub
overnight
grown
confluenc
serial
dilut
quercetin
preincub
viru
tcid
min
cell
wash
twice
phosphat
buffer
salin
pb
inocul
viruscompound
mixtur
anoth
min
inocul
cell
wash
remov
unabsorb
viru
sustain
serumfre
dmem
supplement
l
ethyl
chloromethyl
keton
tpck
trypsin
h
postinfect
inhibit
viral
replic
evalu
determin
protect
virusinduc
cytopath
effect
microscopi
ic
valu
calcul
formazanbas
bromid
mtt
cell
viabil
assess
assay
experi
repeat
least
three
time
confirm
inhibitori
activ
viral
ha
gene
replic
mdck
cell
detect
quantit
realtim
pcr
briefli
confluent
cell
monolay
plate
infect
influenza
apuerto
viru
pretreat
quercetin
describ
infect
cell
wash
twice
pb
remov
unabsorb
viru
sustain
serumfre
dmem
supplement
tpcktrypsin
h
postinfect
total
mrna
extract
trizol
reagent
subsequ
reversetranscrib
cdna
use
primescript
rt
reagent
kit
takara
dalian
china
accord
manufactur
instruct
quantit
realtim
pcr
complet
realtim
pcr
instrument
appli
biosystem
foster
ca
usa
sybr
premix
ex
taq
takara
refer
gene
antiglyceraldehyd
dehydrogenas
gapdh
use
normal
ha
gene
mrna
express
level
fold
chang
ha
gene
express
calcul
use
classic
method
similarli
experi
conduct
cell
line
indic
cell
line
select
quercetin
antivir
activ
sampl
run
triplic
primer
sequenc
gene
list
tabl
tabl
primer
sequenc
quantit
real
time
pcr
haforward
harevers
gapdhforward
gapdhrevers
confluent
mdck
cell
plate
infect
quercetinpretr
influenza
apuerto
viru
describ
h
postinfect
supernat
aspir
cell
wash
pb
next
cell
fix
paraformaldehyd
room
temperatur
min
block
albumin
bovin
serum
bsa
h
incub
nucleoprotein
np
antibodi
dilut
bsa
santa
cruz
ca
usa
overnight
cell
incub
fluorescein
isothiocyanat
fitc
label
secondari
antibodi
dilut
bsa
h
room
temperatur
nucleu
stain
dapi
room
temperatur
min
fluoresc
observ
use
invert
fluoresc
microscop
nikon
eclips
tisam
tokyo
japan
total
three
independ
experi
perform
least
three
photograph
randomli
taken
well
investig
stage
quercetin
effect
conduct
timeofaddit
assay
yu
et
al
report
monolay
mdck
cell
grown
plate
infect
influenza
apuerto
viru
treat
quercetin
concentr
differ
time
interv
turn
h
h
h
h
h
h
postinfect
total
protein
mrna
isol
cell
radio
immun
precipit
assay
ripa
lysi
buffer
contain
proteas
phosphatas
inhibitor
well
trizol
reagent
describ
equal
amount
protein
resolv
sdspage
transfer
polyvinyliden
difluorid
pvdf
membran
roch
indianapoli
usa
mous
monoclon
antiha
dilut
sino
biolog
beij
china
rabbit
monoclon
anti
antibodi
dilut
use
primari
antibodi
antimous
antirabbit
alkalin
phosphatas
ap
conjug
antibodi
use
secondari
antibodi
dilut
chemiluminesc
signal
develop
lumiglo
reagent
cell
signal
technolog
danver
usa
expos
xray
film
fujifilm
europ
gmbh
dusseldorf
germani
time
ha
gene
mrna
level
detect
via
quantit
realtim
pcr
complet
realtim
pcr
instrument
appli
biosystem
foster
ca
usa
describ
interact
influenza
ha
quercetin
analyz
plexarray
ht
system
plexera
bioscienc
beij
china
room
temperatur
quercetin
immobil
sensor
chip
subsequ
recombin
influenza
ha
sino
biolog
inc
beij
china
inject
analyt
variou
concentr
use
phosphat
buffer
salin
pbst
mm
phosphat
buffer
mm
kcl
mm
nacl
tween
ph
run
buffer
bind
studi
protein
appli
correspond
concentr
run
buffer
flow
rate
contact
time
dissoci
time
chip
platform
regener
glyhcl
ph
wash
run
buffer
possibl
bind
curv
fit
langmuir
equat
k
figur
influenza
ha
protein
label
nanotemp
technolog
bavaria
germani
appli
final
concentr
nm
correspond
unlabel
bind
partner
quercetin
titrat
twofold
dilut
seri
pbst
buffer
contain
dimethyl
sulfoxid
dmso
ph
subsequ
dilut
point
mix
label
ha
protein
solut
incub
room
temperatur
min
sampl
fill
hydrophil
capillari
nanotemp
technolog
measur
mst
experi
perform
monolith
system
nanotemp
technolog
lightemit
diod
led
infrar
radiat
ir
laser
power
laser
time
set
respect
hi
assay
conduct
evalu
inhibitori
effect
quercetin
subunit
mediat
viral
adsorpt
cellular
sialic
acid
receptor
lowest
viral
titer
caus
aggreg
chicken
red
blood
cell
crbc
defin
ha
unit
hau
viru
titer
hau
use
assay
hi
assay
twofold
serial
dilut
quercetin
mix
volum
influenza
viru
apuerto
room
temperatur
min
mixtur
subsequ
incub
crbc
room
temperatur
inhibit
hemagglutin
quercetin
observ
h
viru
absenc
quercetin
use
neg
control
pb
use
blank
control
accord
luo
et
al
crbc
wash
pb
store
alsev
solut
use
compound
dilut
pb
mix
influenza
viru
apuerto
strain
tcid
ml
equal
volum
incub
viruscompound
mixtur
room
temperatur
min
prewarm
crbc
ad
mixtur
mixtur
incub
anoth
min
afterward
sodium
acet
ph
ad
mix
well
erythrocyt
suspens
trigger
hemolysi
subsequ
allow
incub
min
plate
centrifug
end
incub
rpm
min
separ
nonlys
erythrocyt
supernat
transfer
anoth
flatbottom
plate
optic
densiti
nm
od
detect
micro
titer
plate
reader
avian
influenza
pseudovirus
express
ha
hiv
human
immunodefici
viru
ha
produc
describ
previous
briefli
cell
cotransfect
plasmid
encod
envdefect
luciferaseexpress
plasmid
includ
qhha
xjha
ahha
respect
mm
cultur
dish
use
polyetherimid
pei
exogen
bacteri
neuraminidas
na
vibrio
cholera
sigma
st
loui
mo
usa
ad
h
later
supernat
harvest
h
posttransfect
singlecycl
infect
pseudotyp
viru
bear
vsv
envelop
glycoprotein
hivvsvg
produc
way
pseudoviru
titer
quantit
use
luciferas
substrat
drug
screen
process
pseudovirus
incub
serial
dilut
compound
min
compoundviru
mixtur
subsequ
ad
cell
h
later
cell
lyse
cell
lysi
buffer
promega
madison
wi
usa
transfer
luminomet
plate
luciferas
substrat
promega
ad
rel
luciferas
activ
determin
ultra
luminomet
genio
pro
tecan
bedford
usa
cytotox
quercetin
mdck
cell
cell
measur
mtt
assay
briefli
cell
well
seed
plate
grown
overnight
medium
replac
fresh
medium
contain
serial
dilut
compound
incub
co
h
cultur
medium
remov
mgml
tetrazolium
bromid
mtt
sigmaaldrich
solut
ad
follow
incub
h
afterward
supernat
aspir
dimethyl
sulfoxid
dmso
ad
well
stain
formazan
product
determin
spectrophotometr
nm
micropl
reader
genio
pro
tecan
bedford
usa
result
shown
deviat
sd
anova
use
test
statist
signific
group
case
p
regard
statist
signific
p
mark
studi
found
quercetin
possess
antiinfluenza
activ
subsequ
mechan
studi
indic
quercetin
show
inhibitori
effect
viru
entri
found
quercetin
interact
influenza
hemagglutinin
protein
inhibit
viralcel
fusion
studi
show
quercetin
may
develop
futur
therapeut
option
therapi
prophylaxi
iav
infect
